Ikapharmindo Putramas Tbk. vs Abadi Lestari Indonesia Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume), while Abadi Lestari Indonesia Tbk. trades at Rp3,260 (market cap 10.06T, 688.4K 24h volume). The key difference: Abadi Lestari Indonesia Tbk. is far larger — about 33× Ikapharmindo Putramas Tbk.'s market cap, and Abadi Lestari Indonesia Tbk. is more actively traded (688.4K versus 13.7K). Which is the better fit depends on your goals.
| IKPM | RLCO | |
|---|---|---|
Market Cap | 304.92B | 10.06T |
Volume | 13.7K | 688.4K |
Lot | 137 | 6.88K |
Turnover | 2.49M | 2.25B |
Average Price | 181.39 | 3,273.17 |
Value | 2.49M | 2.25B |
Indicative Equilibrium Price | — | 3,260 |
Indicative Equilibrium Volume | — | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →